100 related articles for article (PubMed ID: 3104051)
1. Why do dyspeptic patients prefer one liquid antacid to another?
Blum AL
Eur J Clin Invest; 1986 Dec; 16(6):515-8. PubMed ID: 3104051
[TBL] [Abstract][Full Text] [Related]
2. Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
Parr SN
Curr Med Res Opin; 1989; 11(9):557-66. PubMed ID: 2692970
[TBL] [Abstract][Full Text] [Related]
3. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin.
Gotthard R; Bodemar G; Brodin U; Jönsson KA
Scand J Gastroenterol; 1988 Jan; 23(1):7-18. PubMed ID: 3278366
[TBL] [Abstract][Full Text] [Related]
4. [Uncharacteristic dyspepsia in general practice. A controlled trial with an antacid (Alminox)].
Nørrelund N; Helles A; Schmiegelow M
Ugeskr Laeger; 1980 Jun; 142(27):1750-3. PubMed ID: 7008299
[No Abstract] [Full Text] [Related]
5. Comparison of dicyclomine with antacid and without antacid in dyspepsia.
Kagan G; Huddlestone L; Wolstencroft P
J Int Med Res; 1984; 12(3):174-8. PubMed ID: 6734920
[TBL] [Abstract][Full Text] [Related]
6. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
[TBL] [Abstract][Full Text] [Related]
7. The GI Cocktail is no more effective than plain liquid antacid: a randomized, double blind clinical trial.
Berman DA; Porter RS; Graber M
J Emerg Med; 2003 Oct; 25(3):239-44. PubMed ID: 14585449
[TBL] [Abstract][Full Text] [Related]
8. The emergency department treatment of dyspepsia with antacids and oral lidocaine.
Welling LR; Watson WA
Ann Emerg Med; 1990 Jul; 19(7):785-8. PubMed ID: 2202240
[TBL] [Abstract][Full Text] [Related]
9. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
10. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial.
Weberg R; Berstad A
Scand J Gastroenterol; 1988 Mar; 23(2):237-43. PubMed ID: 3283918
[TBL] [Abstract][Full Text] [Related]
11. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Rappaport BS
N Engl J Med; 1986 Sep; 315(12):763-4. PubMed ID: 3528852
[No Abstract] [Full Text] [Related]
12. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
Graham DY; Patterson DJ
Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
[TBL] [Abstract][Full Text] [Related]
13. Why do apparently healthy people use antacid tablets?
Graham DY; Smith JL; Patterson DJ
Am J Gastroenterol; 1983 May; 78(5):257-60. PubMed ID: 6846300
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of foaming antacid in relieving induced heartburn.
Lanza FL; Smith V; Page-Castell JA; Castell DO
South Med J; 1986 Mar; 79(3):327-30. PubMed ID: 3513329
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
[TBL] [Abstract][Full Text] [Related]
16. [Double-blind clinical study of the therapeutic use of new antacid: hydrotalcite].
Meloni M; Palmas S
Clin Ter; 1979 May; 89(3):283-94. PubMed ID: 380881
[No Abstract] [Full Text] [Related]
17. Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes.
Berstad A; Alexander B; Weberg R; Serck-Hanssen A; Holland S; Hirschowitz BI
Gastroenterology; 1988 Sep; 95(3):619-24. PubMed ID: 3294081
[TBL] [Abstract][Full Text] [Related]
18. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
Nyrén O; Adami HO; Bates S; Bergström R; Gustavsson S; Lööf L; Nyberg A
N Engl J Med; 1986 Feb; 314(6):339-43. PubMed ID: 3511376
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis.
Weberg R; Berstad A
Scand J Gastroenterol; 1989 May; 24(4):401-6. PubMed ID: 2675302
[TBL] [Abstract][Full Text] [Related]
20. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
Petrokubi RJ; Jeffries GH
Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
